Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Twist Bioscience (TWST) through the VizualStocks API.
Revenue from products shipped to customers in the United States, Canada, Mexico and South America. Twist assigns geography by ship-to destination, not customer headquarters or where the order was placed.
americasRevenueRevenue from products shipped to Asia Pacific destinations, principally Japan, China, South Korea, India, Singapore, Malaysia, Australia, New Zealand, Thailand and Taiwan. It is based on the customer's shipping address rather than headquarters.
asiaPacificRevenueRevenue from products shipped to customers in Europe, the Middle East and Africa. Twist assigns the region by ship-to destination rather than customer headquarters or billing address.
europeMiddleEastAndAfricaRevenueUnique 'Bill To' accounts that purchased Twist products during the period; one customer can have multiple shipping locations and contacts. Quarterly values count purchasers in that quarter, while fiscal-year values count customers served during the year rather than a period-end installed base.
numberOfCustomersCount of synthetic genes shipped to customers reported by Twist Bioscience during the period. This is activity over the reporting period rather than a period-end population.
numberOfGenesShippedAnnual value of customer contracts and purchase orders received by Twist, including blanket orders as quantities are released. It is a leading indicator of possible future revenue, but orders may not convert to revenue and the timing of recognition can vary.
orderValuePercentage of annual revenue generated from customers that purchased Twist products or services more than once during the fiscal year. It measures repeat adoption and customer engagement, not a dollar amount of revenue.
revenueFromRepeatCustomersMis-mapped legacy dataset field whose populated historical values correspond to Twist's quarterly revenue, not a count of customer orders. It should not be interpreted as order volume and should be replaced or removed when the underlying mapping is curated.
totalOrdersHistorical revenue from universities, research institutes and other academic customers using Twist's synthetic DNA and NGS products for education and scientific discovery. Beginning in fiscal 2026, Twist replaced this category with the broader Academic Research and Government classification.
academicResearchRevenueHistorical revenue from antibody-library design, screening, optimization and related biologics-discovery services used by drug developers. Beginning in fiscal 2026, Twist combined these services with synthetic genes, oligo pools and DNA libraries in DNA Synthesis and Protein Solutions.
antibodyDiscoveryRevenueHistorical revenue from custom collections of DNA variants used to screen biological function, engineer proteins and discover therapeutic candidates. Beginning in fiscal 2026, Twist combined DNA libraries with its other synthetic-DNA and antibody-discovery offerings in DNA Synthesis and Protein Solutions.
dnaLibrariesRevenueHistorical revenue from customers using synthetic DNA and sequencing tools for agricultural biotechnology, crop improvement, food ingredients and related applications. Beginning in fiscal 2026, Twist replaced this narrow category within its broader Industry and Applied customer classification.
foodAndAgricultureRevenueHistorical revenue from biotechnology, pharmaceutical and diagnostic customers using Twist products for disease research, therapeutic discovery and diagnostic development. Beginning in fiscal 2026, Twist split this broad category into separate Therapeutics and Diagnostics classifications.
healthcareRevenueHistorical revenue from customers applying synthetic biology to develop chemicals, materials, fragrances, food additives and other industrial products. Beginning in fiscal 2026, Twist replaced this category with the broader Industry and Applied classification.
industrialChemicalsAndMaterialsRevenueRevenue from target-enrichment panels and probes, library-preparation products and other tools that help customers prepare and analyze samples in DNA sequencing workflows. Twist renamed this category NGS Applications in fiscal 2026 to better describe the role of the products and services.
nextGenerationSequencingToolsRevenueNumber of customer shipments completed during the period, as reported by Twist Bioscience. This is a unit or activity count, not a monetary value.
numberOfShipmentsHistorical revenue from custom mixtures containing many designed short DNA sequences, produced together for high-throughput screening and synthetic-biology experiments. Beginning in fiscal 2026, Twist combined oligo pools with its other synthetic-DNA and antibody-discovery offerings in DNA Synthesis and Protein Solutions.
oligoPoolsRevenueHistorical revenue from made-to-order DNA sequences manufactured on Twist's silicon-based synthesis platform for research, therapeutic, diagnostic and industrial applications. Beginning in fiscal 2026, Twist combined synthetic genes with other synthetic-DNA products and antibody-discovery services in DNA Synthesis and Protein Solutions.
syntheticGenesRevenue